Rare Diseases & Orphan Drug Research

Rare Diseases & Orphan Drug Research focuses on the identification, study, and development of treatments for conditions affecting small patient populations. It promotes innovation through specialized clinical research, regulatory incentives, and patient-centric approaches to improve diagnosis, access to therapies, and long-term health outcomes for individuals living with rare conditions. Rare disease research advances targeted therapies and orphan drugs to address unmet medical needs in small and underserved patient populations.

Examples of Rare Diseases

• Cystic Fibrosis
• Duchenne Muscular Dystrophy
• Huntington’s Disease
• Spinal Muscular Atrophy

Key Focus Areas

• Genetic and molecular disease research
• Early and accurate diagnostic methods
• Development of targeted and personalized therapies
• Clinical trials for small patient populations
• Patient advocacy and access to treatment

Importance of Orphan Drug Research

• Addresses unmet medical needs
• Encourages innovation in precision medicine
• Improves survival and quality of life
• Advances understanding of genetic disorders